• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:沈琴,王晓萍,强磊.药物引起的肝损伤发病机制研究进展[J].药学研究,2022,41(9):595-599[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2302次   下载 2215次 本文二维码信息
码上扫一扫!
药物引起的肝损伤发病机制研究进展
沈琴,王晓萍,强磊
字体:加大+|默认|缩小-
(中国药科大学基础医学与临床药学学院,天然药物国家重点实验室,江苏 南京 211198)
摘要:
药物性肝损伤(drug-induced liver injury,DILI)是由药物或其代谢产物乃至辅料所引起的肝损伤,是目前临床上常见的药品不良反应之一。药物性肝损伤在我国的发生率偏高,仅次于病毒性肝炎和脂肪性肝病。在欧美,药物性肝损伤是引发肝衰竭的主要原因。尽管人们早已意识到药物性肝损伤的危害,但由于其病因复杂,临床表现不具有特异性,诊断标记物特异性不强,导致药物性肝损伤患者常常无法及时被确诊,最终发展为肝衰竭甚至死亡。已知目前有超过1 100种药物可以在不同程度上引起肝损伤。因此,本文主要总结了不同类型药物诱发肝损伤的不同作用机制,为日后药物性肝损伤的预防和治疗提供了一定的理论基础。
关键词:  药物性肝损伤  分子机制  研究进展
DOI:10.13506/j.cnki.jpr.2022.09.007
基金项目:中央高校基本科研业务费专项资金(No.2632022ZD05)
出版日期:2022-09-25
Research progress on the pathogenesis of drug-induced liver injury caused by different drugs
SHEN Qin,WANG Xiaoping,QIANG Lei
(State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Drug-induced liver injury(DILI) is caused by drugs or their metabolites or excipients, which is one of the common adverse drug reactions in clinical practice. DILI has a high incidence in China, second only to viral hepatitis and fatty liver disease. DILI is a leading cause of liver failure in Europe and the United States. Although people have long been aware of the harm of drug-induced liver injury, due to its complex etiology, non-specific clinical manifestations and weak specificity of diagnostic markers, patients with drug-induced liver injury often cannot be diagnosed in time and eventually develop liver failure or even death. More than 1 100 drugs are known to cause liver damage to varying degrees. Therefore, this paper reviewed the pathogenesis of drug-induced liver injury from the perspective of etiology, hoping to give readers a more comprehensive and in-depth understanding of DILI.
Key words:  Drug-induced liver injury  Molecular mechanism  Research progress
今日访问量:2469    总访问量:55338898
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司